Thus, this study aims to examine the role of Erbb4-IR for hypertensive heart disease by specifically silencing cardiac Erbb4-IR in a mouse model of Ang II-induced hypertension to determine its potential as a therapeutic target. This evidence concerns the gene AGT and hypertensive heart disease.